Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 7:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 9,935 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Single-arm Clear all

Conditions: Primary Graft Dysfunction
Interventions: Sodium Nitrite; Drug
Lead sponsor: Gladwin, Mark, MD; Individual
Eligibility: 18 Years to 70 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Parkinson Disease, Freezing of Gait, Deep Brain Stimulation
Interventions: CereGate Software; BSN cDBS Programmer; BSN Burst Programmer; Device
Lead sponsor: CereGate Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 7
States / cities: Redwood City, California • Aurora, Colorado • Miami, Florida + 4 more

Conditions: Adult Growth Hormone Deficiency
Interventions: Somapacitan; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2032
U.S. locations: 29
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 20 more

Conditions: Parenting, Adolescent - Emotional Problem, Mental Disorder in Adolescence
Interventions: Parenting Wisely Residential Treatment (PWRT), TAU; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 11 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Eosinophilic Esophagitis
Interventions: Retrospective evaluation of endoscopy prior to study drug, Symptom Survey, Medication Compliance Phone Call, Endoscopy while on study drug, Fluticasone, Omeprazole, Placebo oral capsule; Diagnostic Test · Other · Drug
Lead sponsor: Claire Daniels; Federal
Eligibility: 6 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Vulvodynia, Vestibulodynia, Vulvar Diseases, Vulvar Vestibulitis, Vulvar Pain
Interventions: BioNourish, a component of the Flourish HEC kit, Control - no intervention; Device · Other
Lead sponsor: Vaginal Biome Science; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Virginia Beach, Virginia

Conditions: Covid-19, Sars-CoV2, Pneumonia
Interventions: Low dose radiation 35 cGy, High dose radiation 100 cGy; Radiation
Lead sponsor: Ohio State University; Other
Eligibility: 50 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 6
States / cities: Boca Raton, Florida • Miami, Florida • Maywood, Illinois + 3 more

Conditions: Hypertrophic Cardiomyopathy
Interventions: Moderate Intensity Exercise Program; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Low Back Pain, Facet Joint Pain
Interventions: iovera system, Radiofrequency ablation; Device
Lead sponsor: Medical Pain Management Services, PLLC; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Saratoga Springs, New York

Conditions: Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders
Interventions: Purified regulatory T-cells (Treg) plus CD34+ HSPC, Fludarabine, Melphalan, CliniMACS CD34 Reagent System, Tacrolimus, Cyclophosphamide, Plerixafor, Filgrastim granulocyte colony-stimulating factor (G-CSF) or equivalent, Thiotepa, Mycophenolate Mofetil (MMF), Ruxolitinib, Sirolimus; Drug · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Health-Related Quality-of-Life, Cancer, Health Communication
Interventions: ReSPECT; Behavioral
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 15 Years to 25 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Stroke
Interventions: No aortic clamping, partial occluding clamp, single cross clamp, cross clamp and partial occluding clamp; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 193 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Interventions: E7050, Cetuximab; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 7
States / cities: Tucson, Arizona • Fort Myers, Florida • Boston, Massachusetts + 4 more

Conditions: Recurrent Epithelial Cancer of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
Interventions: Avelumab; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cervical Cancer Screening
Interventions: HPV Self-Sampling; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 25 Years to 65 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy Volunteer, Hepatic Impairment (HI)
Interventions: varegacestat; Drug
Lead sponsor: Immunome, Inc.; Industry
Eligibility: 18 Years to 84 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Orlando, Florida • San Antonio, Texas

Conditions: H Pylori Infection, H Pylori Gastritis, Gastric Cancer
Interventions: PYTEST® 14C-Urea Breath Test, VOQUEZNA® Triple Pak®; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 430 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Burden, Caregiver
Interventions: Yoga; Support Group; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Asthma
Interventions: HXe MRI guided treatment sequence for BT, Standard treatment sequence for BT (control); Drug · Other
Lead sponsor: Xemed LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Knee Injuries and Disorders, Shoulder Disease, Shoulder Injuries
Interventions: C Scope Visualization System; Device
Lead sponsor: CIT Ortho; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Henderson, Nevada

Conditions: Osteopenia, Osteoporosis, Bone Disease
Interventions: RN564; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 55 Years to 80 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 8
States / cities: Coral Gables, Florida • Miami, Florida • South Miami, Florida + 1 more

Conditions: Metastatic Pancreatic Adenocarcinoma
Interventions: metformin alone (Arm A), metformin (Arm B), rapamycin (Arm B); Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: Scottsdale, Arizona • Baltimore, Maryland

Conditions: TQT Study
Interventions: Tetrodotoxin, Placebos; Drug
Lead sponsor: Wex Pharmaceuticals Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Schizophrenia
Interventions: RBP-7000, risperidone; Drug
Lead sponsor: Indivior Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Willingboro, New Jersey

Search by objective public record fields.

Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction

Use of CereGate Therapy for Freezing of Gait in PD

A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information

Optimizing Residential Treatment Gains for Adolescents

EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone

Effects of Flourish HEC on Localized Provoked Vulvodynia

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia

Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy

Cryoneurolysis for Facet Mediated Chronic Low Back Pain

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Improving Sexual and Reproductive Health Communication for Adolescent and Young Adult Oncology Patients

Stroke Study: Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery

E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck

Anti-PD-L1 and SAbR for Ovarian Cancer

Emergency Room HPV Self-Sampling Study (ACT NOW)

A Varegacestat Hepatic Impairment Study

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

Social Support and Stress Reduction for Caregivers of Young Adults With IDD

Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI

C Scope Visualization System Prospective Study

Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.

A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects

Single Ascending Dose Study of RBP-7000